Morphology and Life Cycle Forms
The life cycle of the pathogen involves multiple forms with fundamentally different clinical significance. The main stages are divided into vegetative and cystic forms.
Vegetative forms (fragile, perish outside the body within 30 minutes):
- Small vegetative (luminal) form or forma minuta: Measures 15–20 µm. Inhabits the upper segments of the large intestine as a harmless commensal. It feeds on detritus and bacteria, and has low motility.
- Pre-cystic form: A transitional stage morphologically similar to the luminal form, preparing for encystation.
- Large vegetative (tissue) form, also known as forma magna or erythrophage: The largest form (approximately 30 µm). Characterized by active, jerky motility driven by pseudopodia. This is the primary pathogenic form. It is capable of phagocytosing blood cells (erythrocytes), which are clearly visible within its cytoplasm.
Resting stage (cyst): An immobile form designed for survival in the external environment. Cysts are oval-shaped and measure 9–16 µm. Crucial diagnostic sign: a fully mature cyst contains exactly 4 nuclei (whereas the non-pathogenic intestinal amoeba Entamoeba coli has 8).
Epidemiology
Amebiasis is a strict anthroponosis; humans are the only reservoir and source of infection. Individuals older than 5 years are predominantly affected, particularly in regions with tropical and subtropical climates.
- Transmission mechanism: Fecal-oral.
- Routes of infection: Waterborne (contaminated water), alimentary (unwashed vegetables and fruits), contact-domestic (dirty hands and household items).
- Vectors: Cysts can be mechanically transmitted by flies and cockroaches.
Cysts possess high resistance: in water at 20 °C, they survive for up to 2 weeks, and on food products for several days. However, they are destroyed by boiling. Notably, cyst shedding is prolific: a single asymptomatic cyst carrier can excrete about 8 million cysts into the environment daily.
Pathogenesis of Intestinal Amebiasis
Once cysts enter the gastrointestinal tract, they excyst into luminal forms. In many cases, they simply reside in the intestine for long periods, establishing asymptomatic colonization.
Under conditions of lowered immunity and with the participation of accompanying intestinal microflora, forma minuta transforms into the tissue form. The parasite actively invades the large intestinal wall, causing coagulation necrosis.
Deep crateriform ulcers with characteristic undermined edges form on the mucous membrane. Clinically, this manifests as fever, dehydration, false urges to defecate (tenesmus), and specific diarrhea: stools become frequent and liquid, containing abundant mucus, pus, and blood ('raspberry jelly' appearance).
Extraintestinal Amebiasis and Immunity
Tissue forms of the amoeba are capable of destroying blood vessels in the intestinal wall, leading to hematogenous dissemination (via the bloodstream) throughout the body.
Metastasis most frequently affects the liver, lungs, and brain. Single or multiple amebic abscesses measuring up to 10 cm can form in these organs. Additionally, a cutaneous form of amebiasis exists, characterized by mildly painful ulcers appearing in the perianal and perineal regions.
The host immune response in amebiasis is transient. Protection is primarily mediated via cellular immunity, while humoral antibodies are produced exclusively in response to tissue invasion.
Principles of Diagnosis and Treatment
Nutrient-rich artificial media are used to cultivate the pathogen. In clinical practice, the diagnosis is confirmed by the following methods:
- Microscopic (primary): Examination of stool smears or abscess contents stained with Lugol's iodine or hematoxylin. It is essential to differentiate E. histolytica from other amoebae (e.g., E. hartmanni, E. gingivalis, Endolimax nana).
- Serological (IHA, ELISA, IFA, CF): Particularly valuable in extraintestinal amebiasis, as abscesses are associated with the highest antibody titers.
- Molecular-biological: PCR diagnostics targeting marker DNA sequences of the pathogen in feces.
First-line treatment includes metronidazole or tinidazole. Other agents historically or adjunctively used include mexaform, osarsol, yatren, chloroquine (delagil), and dehydroemetine. Prevention relies on identifying cyst excretors and implementing strict general sanitary measures.